The Semax and Selank combination puts two short peptides in one vial. They share a research tradition, which explains why they are discussed and stocked together, and says nothing about whether they behave alike as materials.
This guide covers what the certificate has to establish for a two-component vial, and what changes about handling when both components are very short sequences.
A shared origin is not a shared chemistry
Each compound has its own sequence, its own mass and its own handling profile. A certificate for one establishes nothing about the other, and the common origin that explains the pairing is a historical fact rather than a chemical one.
Semax and Selank: two peptides from the same research tradition covers the compounds individually.
What a combination certificate has to show
| Panel | Strong version | Weak version |
|---|---|---|
| Identity | Both confirmed independently | One confirmed, one inferred |
| Purity | Reported per component | A single combined figure |
| Ratio | Measured on the finished material | The intended ratio restated |
| Content | Per component, each named | One number with no component stated |
| Chromatogram | Two resolved peaks | A single peak |
Two compounds in one vial means every field has to be answered twice.
The content line usually reports one component rather than the vial total, so a figure that looks like half the label is often correct. Blends and single vials covers the reading.
Why the arithmetic is easy to check here
Both components are short, well-defined sequences, which makes the mass calculable rather than something to accept on trust. Sum the residue masses for each sequence, add one water, and compare against the figures the certificate reports.
A gap that nothing accounts for is unusual enough to raise before the material is used. Molecular weight covers the method and the two reasons a correct number can look wrong.
What changes at this chain length
The failure modes that dominate longer peptides largely disappear. Aggregation needs enough chain to present a hydrophobic face, and these sequences do not have one. What replaces it is exposure at the termini, because a very short chain is almost entirely termini with no protected interior.
That means handling guidance written for structured peptides, about avoiding unfolding and surface denaturation, is aimed at a problem these compounds do not have. Why some peptides resist dissolving covers what does apply.
Solvent, for two compounds at once
The solvent has to suit both components rather than one, which is the real constraint a blend introduces. Where the two differ in charge, a solvent ideal for one may sit closer to the isoelectric point of the other.
In practice both of these are short and water-liking enough that a plain aqueous diluent suits them, which is why the combination is viable at all. Reconstitution solvents compared covers the options.
What the fixed ratio costs
The proportion is set at manufacture and cannot be adjusted downstream. A blend is therefore the right purchase when the ratio is already settled by earlier work, and the wrong one while it is still a variable you expect to change.
What to record
- Both compounds by name in the same log entry, with the lot.
- The per-component content figures rather than a single number.
- The measured ratio where the certificate reports one.
- Your own copy of the certificate rather than a link to the supplier archive.
Records to keep covers how those tie together into something that answers a question later.
Scope
The Semax and Selank combination is supplied for laboratory research only. Nothing here describes effects in any organism, and nothing on a certificate speaks to them.
In short
Two short peptides sharing a tradition and not a chemistry. Require identity and purity per component and a measured ratio, check both masses against their sequences since that is easy at this length, and buy the blend only once the ratio is settled.
Comparing suppliers for a short-peptide blend
The documentation bar is the same as any combination product and the arithmetic check is easier, because both sequences are short enough that the masses can be calculated and compared in a couple of minutes. That makes this a blend where a buyer can verify more than usual without equipment.
Use it. A supplier whose two reported masses both reconcile against their stated sequences has demonstrated something concrete, and one whose figures do not is worth a question before the order.
Storage and handling
Both components are short, unstructured and water-liking, which makes the material comparatively forgiving as a dry solid and straightforward to reconstitute. The clock that matters starts at reconstitution rather than at delivery.
Once in solution the usual controls apply: cold, dark, closed, and as few entries as the work allows. Vial closures covers why entry count is a limit alongside elapsed time.
On arrival
- Match the lot on the vial to its certificate, reading the full string.
- Check both reported masses against the two published sequences.
- Confirm which component the content figure describes.
- Inspect the cake and record anything unexpected in writing before storage.
What to record
Both compounds by name in the same entry with the lot, both content figures, the measured ratio where reported, and your own copy of the certificate rather than a link to the supplier archive.
Where this sits
For the two compounds individually, Semax and Selank: two peptides from the same research tradition. For combination products generally, blends and single vials. For the wider buying process, wholesale peptides for clinics.
A note on naming
Both compounds circulate under more than one designation, and a blend described only by two product names has not established which molecules are in the vial. Ask for the sequences, which is a short question with a definitive answer.
Building the habit
The checks in this guide take minutes and they only work if they happen every time rather than when someone remembers. Two things make that realistic: a named person who owns receiving, and a form short enough that a busy day does not defeat it.
Writing an SOP for peptide receipt and storage covers turning the checks into something a practice actually follows, and chain of custody inside a practice covers the four points where the record usually breaks.
Choosing between the blend and two vials
Buy the blend when the ratio is settled and both compounds are used together every time. Buy single vials while the proportion is still a variable, because a blend fixes it at manufacture and a design that later needs a different ratio has to start again.
For two short, inexpensive peptides the cost difference is usually small enough that flexibility is worth more than convenience until the work is settled.
What short length changes about the purchase
It makes the certificate unusually checkable. Both sequences are short enough to calculate a mass for in a couple of minutes, which means a buyer can verify the two most important figures on the document without equipment or expertise.
Few purchases in this catalogue offer that. It is worth using rather than skipping, because it is the one check that does not depend on trusting anyone.
What this guide does not cover
What either compound does. That belongs to the literature and nothing on a certificate addresses it. A buyer settles which molecules are present, in what proportion, at what purity, and whether the document describes their lot.
Reading the quote
A wholesale quote carries four things: a unit price, a minimum quantity, the documentation included with the order, and the terms under which you pay. Only the first is read closely by most buyers and it is the one that tells you least about what the order will actually cost.
Documentation is the line that separates two identical-looking quotes, and terms change the real price more than the unit price does. Thirty days to pay on a four-figure order is worth roughly a month of the cost of capital. How to read a wholesale peptide quote takes all four apart.
Minimums, and what to do about them
A minimum order quantity is set by how material is manufactured rather than by a sales department. Synthesis runs at a batch scale and the cost is dominated by setup, purification and testing rather than by mass, so halving an order does not halve the cost.
Where the minimum exceeds what you can use before the material ages out, the honest responses are to order less often, consolidate across compounds so one order clears it, or drop the item from the formulary. Minimum order quantities covers which minimums move and which do not.
Because both components are inexpensive relative to much of this catalogue, the minimum rather than the unit price is usually what decides the order size here, which makes the per-order versus per-line question worth asking explicitly.
A short pre-order checklist
Five questions, one email, about fifteen minutes. Can you send the certificate for a lot I would actually receive. Which laboratory issued it and what is it accredited for. Which salt form is supplied. What is the lead time for in stock against made to order. And what happens if a lot is withdrawn after I have taken delivery.
The answers matter and so does how they arrive: how quickly, whether they address what was asked, and whether they come from someone who can see the document rather than relaying it. Auditing a peptide supplier is the longer version, and comparing suppliers on documentation covers weighing the replies against each other.
For where this sits among the other molecules and formats a catalogue carries, not everything in a peptide catalog is a peptide covers how the classes differ.